Seth Pollack, MD


Dr. Seth M. Pollack is an expert on sarcomas, cancers of the bone and soft tissues. Dr. Pollack’s research is focused on the development of novel immunotherapies for patients with advanced sarcoma. His laboratory has used a variety of methodologies to characterize the sarcoma tumor immune microenvironment resulting in multiple on-going novel checkpoint inhibitor trials. He has a particular focus on developing novel therapies for Synovial Sarcoma and Myxoid/ Round Cell Liposarcoma, two sarcoma types that generally have strong expression of the immunotherapeutic target NY-ESO-1. Dr. Pollack also sees sarcoma patients at the Seattle Cancer Care Alliance (a partnership between the Fred Hutch, UW and Seattle Children’s Hospital).